Medical Treatment for Endometriosis: Tolerability, Quality of Life and Adherence

Giussy Barbara, Laura Buggio, Federica Facchin, Paolo Vercellini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Endometriosis is associated with painful symptoms, infertility, sexological difficulties, and psychological suffering. All these symptoms have a negative impact on the overall quality of life of women with the disease, with significant personal, social and economic costs. Several medical options are available to manage symptomatic endometriosis. The pharmacological treatment for endometriosis-related pain may be necessary for decades, or at least until there is a desire for pregnancy or physiologic menopause occurs. In this perspective, clinicians should consider not only the efficacy, but also side effects, tolerability, and costs, along with women's preferences toward different treatments. In this mini-review, we analyzed the pros and cons of the available drugs for the medical therapy of endometriosis, such as estrogen-progestins, progestins, GnRH agonist and GnRH antagonists.
Lingua originaleEnglish
pagine (da-a)1-6
Numero di pagine6
RivistaFRONTIERS IN GLOBAL WOMEN’S HEALTH
Volume2
DOI
Stato di pubblicazionePubblicato - 2021

Keywords

  • endometriosis
  • estrogen-progestins
  • GnRH agonists
  • tolerability
  • medical treatment
  • quality of life
  • GnRH antagonists

Fingerprint

Entra nei temi di ricerca di 'Medical Treatment for Endometriosis: Tolerability, Quality of Life and Adherence'. Insieme formano una fingerprint unica.

Cita questo